Maternal use of SSRIs associated with fewer depressive symptoms, delayed fetal head growth
Treating pregnant women with selective serotonin reuptake inhibitors (SSRIs) appears to be associated with fewer depressive symptoms, reduced fetal head growth and a higher risk for preterm birth, but not with a delay in ...
Mar 5, 2012
0
0